Catalyst Alerts

Get notified when biotech catalysts fire — FDA dates, trial updates, insider buying, and more.

Sign in to manage your alerts
Sign In →
Recent Catalyst Events
■
DFTXDefinium Therapeutics, Inc.2026-11-09
Regulatory milestone + open offering window: DFTX
■
RVMDRevolution Medicines2026-11-04
FDA approval + open offering window: RVMD
■
URGNUroGen Pharma Ltd.2026-11-04
Regulatory milestone + open offering window: URGN
■
INOInovio Pharmaceuticals, Inc.2026-11-02
FDA approval + open offering window: INO
■
AGIOAgios Pharmaceuticals2026-10-26
PDUFA in 6 days: AGIO — mitapivat — sickle cell disease
■
INOInovio Pharmaceuticals, Inc.2026-10-26
PDUFA in 4 days: INO — INO (Inovio Pharmaceuticals, Inc.) — PDUFA date
■
ABSIAbsci Corporation2026-04-22
Short Squeeze Setup: ABSI — 29.5% float short, HIGH squeeze risk
■
ABCLAbCellera Biologics2026-04-22
Short Squeeze Setup: ABCL — 22.7% float short, HIGH squeeze risk
■
ABEOAbeona Therapeutics Inc.2026-04-22
Short Squeeze Setup: ABEO — 32.4% float short, HIGH squeeze risk
■
ACHCAcadia Healthcare Company, Inc.2026-04-22
Short Squeeze Setup: ACHC — 27.2% float short, HIGH squeeze risk
■
ACLX2026-04-22
Short Squeeze Setup: ACLX — 23.5% float short, HIGH squeeze risk
■
ANABAnaptysBio Inc2026-04-22
Short Squeeze Setup: ANAB — 27.9% float short, HIGH squeeze risk
■
ARCTArcturus Therapeutics Holdings Inc.2026-04-22
Short Squeeze Setup: ARCT — 24.5% float short, HIGH squeeze risk
■
ASMBAssembly Biosciences2026-04-22
Short Squeeze Setup: ASMB — 20.4% float short, HIGH squeeze risk
■
ATYRaTyr Pharma, Inc.2026-04-22
Short Squeeze Setup: ATYR — 20.5% float short, HIGH squeeze risk
■
AUTLAutolus Therapeutics2026-04-22
Short Squeeze Setup: AUTL — 43.0% float short, HIGH squeeze risk
■
AVBPArriVent BioPharma, Inc.2026-04-22
Short Squeeze Setup: AVBP — 28.0% float short, HIGH squeeze risk
■
AVTXAvalo Therapeutics, Inc.2026-04-22
Short Squeeze Setup: AVTX — 27.5% float short, HIGH squeeze risk
■
AVXLAnavex Life Sciences2026-04-22
Short Squeeze Setup: AVXL — 21.4% float short, HIGH squeeze risk
■
BBNXBeta Bionics, Inc.2026-04-22
Short Squeeze Setup: BBNX — 32.2% float short, HIGH squeeze risk
Not financial advice. BiotechSign alerts are for research and informational purposes only.